Mrinmoy Sarkar

945 total citations · 1 hit paper
27 papers, 652 citations indexed

About

Mrinmoy Sarkar is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Mrinmoy Sarkar has authored 27 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 4 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Cancer Research. Recurrent topics in Mrinmoy Sarkar's work include Metabolism, Diabetes, and Cancer (4 papers), Circadian rhythm and melatonin (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Mrinmoy Sarkar is often cited by papers focused on Metabolism, Diabetes, and Cancer (4 papers), Circadian rhythm and melatonin (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Mrinmoy Sarkar collaborates with scholars based in India, United States and Bangladesh. Mrinmoy Sarkar's co-authors include Biplab Giri, Sananda Dey, Tanaya Das, Jhimli Banerjee, Sandeep Kumar Dash, Tapasree Roy Sarkar, Labanyamoy Kole, Priyabrata Sarkar, Suparna Saha and Amit Kumar Dixit and has published in prestigious journals such as Oncogene, British Journal of Pharmacology and Cellular and Molecular Life Sciences.

In The Last Decade

Mrinmoy Sarkar

25 papers receiving 640 citations

Hit Papers

Chronic hyperglycemia mediated physiological alteration a... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity
    2018 388 citations Biplab Giri, Sananda Dey et al. Biomedicine & Pharmacotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mrinmoy Sarkar India 10 208 188 78 75 69 27 652
Bikash Manandhar Australia 17 417 2.0× 195 1.0× 64 0.8× 75 1.0× 78 1.1× 35 1.0k
Saeed Nazari Soltan Ahmad Iran 19 293 1.4× 90 0.5× 59 0.8× 73 1.0× 41 0.6× 32 754
Mariana Deleanu Romania 18 249 1.2× 90 0.5× 47 0.6× 53 0.7× 49 0.7× 34 759
Jing Cheng China 16 400 1.9× 82 0.4× 61 0.8× 59 0.8× 43 0.6× 34 877
Osama M. Ashour Saudi Arabia 14 250 1.2× 74 0.4× 147 1.9× 70 0.9× 32 0.5× 34 820
Víctor Pallarès Spain 20 343 1.6× 91 0.5× 112 1.4× 52 0.7× 129 1.9× 30 883
Arzu Onay-Beşi̇kçi̇ Türkiye 17 356 1.7× 68 0.4× 47 0.6× 51 0.7× 149 2.2× 37 941
Khaled Alhosaini Saudi Arabia 16 278 1.3× 76 0.4× 85 1.1× 48 0.6× 57 0.8× 44 794
Hye Yeon Choi South Korea 12 362 1.7× 156 0.8× 63 0.8× 75 1.0× 144 2.1× 17 983
Yuanyuan Zhai China 19 414 2.0× 102 0.5× 45 0.6× 55 0.7× 77 1.1× 44 965

Countries citing papers authored by Mrinmoy Sarkar

Since Specialization
Citations

This map shows the geographic impact of Mrinmoy Sarkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mrinmoy Sarkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mrinmoy Sarkar more than expected).

Fields of papers citing papers by Mrinmoy Sarkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mrinmoy Sarkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mrinmoy Sarkar. The network helps show where Mrinmoy Sarkar may publish in the future.

Co-authorship network of co-authors of Mrinmoy Sarkar

This figure shows the co-authorship network connecting the top 25 collaborators of Mrinmoy Sarkar. A scholar is included among the top collaborators of Mrinmoy Sarkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mrinmoy Sarkar. Mrinmoy Sarkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarkar, Mrinmoy, James Sampson, Yava Jones‐Hall, et al.. (2025). LILRB4 regulates circadian disruption-induced mammary tumorigenesis via non-canonical WNT signaling pathway. Oncogene. 44(46). 4491–4504. 1 indexed citations
2.
3.
Sarkar, Mrinmoy, et al.. (2025). Tumor-associated macrophages contribute to cisplatin resistance via regulating Pol η-mediated translesion DNA synthesis in ovarian cancer. Cellular and Molecular Life Sciences. 82(1). 220–220. 2 indexed citations
4.
Ghosh, A., Mrinmoy Sarkar, Mahul Chakraborty, et al.. (2025). Rhythm is essential: Unraveling the relation between the circadian clock and cancer. Critical Reviews in Oncology/Hematology. 208. 104632–104632. 2 indexed citations
5.
Saha, Priyanka, Mrinmoy Sarkar, Amit Kumar Dixit, et al.. (2025). Inhibition of DNA polymerase eta‐mediated translesion DNA synthesis with small molecule sensitises ovarian cancer stem‐like cells to chemotherapy. British Journal of Pharmacology. 182(15). 3594–3611. 2 indexed citations
6.
Sarkar, Mrinmoy, et al.. (2023). MicroRNAs: Key modulators of inflammation-associated diseases. Seminars in Cell and Developmental Biology. 154(Pt C). 364–373. 18 indexed citations
7.
Sarkar, Mrinmoy, et al.. (2023). Cancer-associated fibroblasts: The chief architect in the tumor microenvironment. Frontiers in Cell and Developmental Biology. 11. 1089068–1089068. 84 indexed citations
8.
Sarkar, Mrinmoy, et al.. (2023). The Cytotoxicity of Carbon Nanotubes and Hydroxyapatite, and Graphene and Hydroxyapatite Nanocomposites against Breast Cancer Cells. Nanomaterials. 13(3). 556–556. 9 indexed citations
9.
Sarkar, Mrinmoy, Sananda Dey, Tanushree Mondal, et al.. (2023). Efficacy and limitations of repurposed drugs and vaccines for COVID-19. 2. 100041–100041. 4 indexed citations
10.
Dixit, Amit Kumar, et al.. (2019). Efficacy of Ayurvedic Interventions in Hypothyroidism. 3(4). 157–163. 3 indexed citations
11.
12.
Giri, Biplab, Sananda Dey, Tanaya Das, et al.. (2018). Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity. Biomedicine & Pharmacotherapy. 107. 306–328. 388 indexed citations breakdown →
13.
Ghosh, Shilpi, Mrinmoy Sarkar, Amitava Mandal, et al.. (2017). Biological evaluation of a halogenated triterpenoid, 2α-bromo-dihydrobelulonic acid as inhibitor of human topoisomerase IIα and HeLa cell proliferation. Chemico-Biological Interactions. 268. 68–76. 12 indexed citations
14.
Giri, Biplab, Mrinmoy Sarkar, & Sananda Dey. (2017). DOUBLE EDGE EFFECT OF DPP4 INHIBITOR SITAGLIPTIN, A TYPE-2 ANTI-DIABETIC DRUG, ON INFLAMMATION, INJURY AND CANCER. 3(1). 1–7. 1 indexed citations
15.
16.
Dey, Sananda, Mrinmoy Sarkar, & Biplab Giri. (2016). Anti-inflammatory and Anti-tumor Activities of Parthenolide: An Update. 1(2). 22 indexed citations
17.
18.
Sarkar, Mrinmoy, et al.. (2016). In Vitro Activity Screening of Snake Venom against Multi Drug Resistant Tuberculosis. Journal of Tropical Diseases. 4(2). 2 indexed citations
19.
20.
Sarkar, Mrinmoy, et al.. (2013). Phytochemical Screening and Anti-microbial Activity Studies on <i>Leea macrophylla</i> Seed Extracts. Journal of Scientific Research. 5(2). 399–405. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bikash Manandhar Breakdown of academic impact, for papers by Saeed Nazari Soltan Ahmad Breakdown of academic impact, for papers by Mariana Deleanu Breakdown of academic impact, for papers by Jing Cheng Breakdown of academic impact, for papers by Osama M. Ashour Breakdown of academic impact, for papers by Víctor Pallarès Breakdown of academic impact, for papers by Arzu Onay-Beşi̇kçi̇ Breakdown of academic impact, for papers by Khaled Alhosaini Breakdown of academic impact, for papers by Hye Yeon Choi Breakdown of academic impact, for papers by Yuanyuan Zhai
Rankless by CCL
2026